The activation of this pathway supports cell survival, interacts with AR signaling, and modulates epigenetic regulators like EZH2 to enable phenotypic shifts.71,72 In both cancer types, the AKT/mTOR pathway functions as a pro-survival signaling mechanism that enhances cell proliferation, supports cellular transitions, and underpins therapy resistance and disease progression. Here, EZH2 is linked to cancer.